Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
New data showed a correlation between the levels of neural cell adhesion…
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Companys Novel Business Model as Key to Sustainable Success through Patient Affordability
Tevogen Bio is a fully functional biotech, with investor-valued assets over $10…